vs
IRONWOOD PHARMACEUTICALS INC（IRWD）与READING INTERNATIONAL INC（RDI）财务数据对比。点击上方公司名可切换其他公司
READING INTERNATIONAL INC的季度营收约是IRONWOOD PHARMACEUTICALS INC的1.1倍（$50.3M vs $47.7M），IRONWOOD PHARMACEUTICALS INC净利率更高（-4.8% vs -5.1%，领先0.3%），READING INTERNATIONAL INC同比增速更快（-14.2% vs -47.3%），IRONWOOD PHARMACEUTICALS INC自由现金流更多（$74.6M vs $4.1M），过去两年READING INTERNATIONAL INC的营收复合增速更高（5.6% vs -20.2%）
Ironwood制药公司是一家上市制药企业，其前身为Microbia公司，专注于制药领域相关业务研发与运营，面向市场开发各类创新医药产品，满足未被充分满足的临床医疗需求。
雷丁公司是总部位于美国费城的铁路企业，1924年起在宾夕法尼亚州东部及周边各州提供客运与货运运输服务，直至1976年被联合铁路公司收购。
IRWD vs RDI — 直观对比
营收规模更大
RDI
是对方的1.1倍
$47.7M
营收增速更快
RDI
高出33.1%
-47.3%
净利率更高
IRWD
高出0.3%
-5.1%
自由现金流更多
IRWD
多$70.5M
$4.1M
两年增速更快
RDI
近两年复合增速
-20.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $47.7M | $50.3M |
| 净利润 | $-2.3M | $-2.6M |
| 毛利率 | — | — |
| 营业利润率 | 14.3% | -1.9% |
| 净利率 | -4.8% | -5.1% |
| 营收同比 | -47.3% | -14.2% |
| 净利润同比 | -200.9% | -14.5% |
| 每股收益（稀释后） | $0.01 | $-0.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IRWDRDI
| Q4 25 | $47.7M | $50.3M | ||
| Q3 25 | $122.1M | $52.2M | ||
| Q2 25 | $85.2M | $60.4M | ||
| Q1 25 | $41.1M | $40.2M | ||
| Q4 24 | $90.5M | $58.6M | ||
| Q3 24 | $91.6M | $60.1M | ||
| Q2 24 | $94.4M | $46.8M | ||
| Q1 24 | $74.9M | $45.1M |
净利润IRWDRDI
| Q4 25 | $-2.3M | $-2.6M | ||
| Q3 25 | $40.1M | $-4.2M | ||
| Q2 25 | $23.6M | $-2.7M | ||
| Q1 25 | $-37.4M | $-4.8M | ||
| Q4 24 | $2.3M | $-2.2M | ||
| Q3 24 | $3.6M | $-7.0M | ||
| Q2 24 | $-860.0K | $-12.8M | ||
| Q1 24 | $-4.2M | $-13.2M |
营业利润率IRWDRDI
| Q4 25 | 14.3% | -1.9% | ||
| Q3 25 | 61.8% | -0.6% | ||
| Q2 25 | 53.2% | 4.8% | ||
| Q1 25 | -70.7% | -17.2% | ||
| Q4 24 | 34.8% | 2.6% | ||
| Q3 24 | 28.0% | -0.6% | ||
| Q2 24 | 26.5% | -16.4% | ||
| Q1 24 | 14.7% | -16.7% |
净利率IRWDRDI
| Q4 25 | -4.8% | -5.1% | ||
| Q3 25 | 32.8% | -8.0% | ||
| Q2 25 | 27.7% | -4.4% | ||
| Q1 25 | -90.9% | -11.8% | ||
| Q4 24 | 2.5% | -3.8% | ||
| Q3 24 | 4.0% | -11.7% | ||
| Q2 24 | -0.9% | -27.4% | ||
| Q1 24 | -5.6% | -29.4% |
每股收益（稀释后）IRWDRDI
| Q4 25 | $0.01 | $-0.11 | ||
| Q3 25 | $0.23 | $-0.18 | ||
| Q2 25 | $0.14 | $-0.12 | ||
| Q1 25 | $-0.23 | $-0.21 | ||
| Q4 24 | $0.03 | $-0.11 | ||
| Q3 24 | $0.02 | $-0.31 | ||
| Q2 24 | $-0.01 | $-0.57 | ||
| Q1 24 | $-0.03 | $-0.59 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $215.5M | $10.5M |
| 总债务越低越好 | — | $185.1M |
| 股东权益账面价值 | $-261.8M | $-18.2M |
| 总资产 | $396.9M | $434.9M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资IRWDRDI
| Q4 25 | $215.5M | $10.5M | ||
| Q3 25 | $140.4M | $8.1M | ||
| Q2 25 | $92.9M | $9.1M | ||
| Q1 25 | $108.5M | $5.9M | ||
| Q4 24 | $88.6M | $12.4M | ||
| Q3 24 | $88.2M | $10.1M | ||
| Q2 24 | $105.5M | $9.3M | ||
| Q1 24 | $121.5M | $7.5M |
总债务IRWDRDI
| Q4 25 | — | $185.1M | ||
| Q3 25 | $199.5M | — | ||
| Q2 25 | $199.3M | — | ||
| Q1 25 | $199.2M | — | ||
| Q4 24 | $199.0M | $202.7M | ||
| Q3 24 | $198.8M | — | ||
| Q2 24 | $198.6M | — | ||
| Q1 24 | $398.3M | — |
股东权益IRWDRDI
| Q4 25 | $-261.8M | $-18.2M | ||
| Q3 25 | $-264.2M | $-12.1M | ||
| Q2 25 | $-308.2M | $-7.7M | ||
| Q1 25 | $-334.1M | $-8.1M | ||
| Q4 24 | $-301.3M | $-4.4M | ||
| Q3 24 | $-311.3M | $1.6M | ||
| Q2 24 | $-321.7M | $6.5M | ||
| Q1 24 | $-330.5M | $18.0M |
总资产IRWDRDI
| Q4 25 | $396.9M | $434.9M | ||
| Q3 25 | $396.1M | $435.2M | ||
| Q2 25 | $342.9M | $438.1M | ||
| Q1 25 | $327.2M | $441.0M | ||
| Q4 24 | $350.9M | $471.0M | ||
| Q3 24 | $389.5M | $495.7M | ||
| Q2 24 | $395.6M | $494.9M | ||
| Q1 24 | $438.8M | $494.9M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $74.6M | $4.3M |
| 自由现金流经营现金流 - 资本支出 | $74.6M | $4.1M |
| 自由现金流率自由现金流/营收 | 156.3% | 8.2% |
| 资本支出强度资本支出/营收 | 0.0% | 0.3% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $127.0M | $-2.9M |
8季度趋势，按日历期对齐
经营现金流IRWDRDI
| Q4 25 | $74.6M | $4.3M | ||
| Q3 25 | $47.6M | $295.0K | ||
| Q2 25 | $-15.1M | $1.6M | ||
| Q1 25 | $20.0M | $-7.7M | ||
| Q4 24 | $15.2M | $8.0M | ||
| Q3 24 | $9.9M | $1.3M | ||
| Q2 24 | $33.5M | $-10.4M | ||
| Q1 24 | $45.0M | $-2.8M |
自由现金流IRWDRDI
| Q4 25 | $74.6M | $4.1M | ||
| Q3 25 | $47.6M | $-246.0K | ||
| Q2 25 | $-15.1M | $1.2M | ||
| Q1 25 | $19.9M | $-8.0M | ||
| Q4 24 | — | $7.0M | ||
| Q3 24 | $9.9M | $-1.1M | ||
| Q2 24 | $33.4M | $-10.6M | ||
| Q1 24 | $44.9M | $-4.7M |
自由现金流率IRWDRDI
| Q4 25 | 156.3% | 8.2% | ||
| Q3 25 | 39.0% | -0.5% | ||
| Q2 25 | -17.7% | 1.9% | ||
| Q1 25 | 48.4% | -19.8% | ||
| Q4 24 | — | 12.0% | ||
| Q3 24 | 10.8% | -1.8% | ||
| Q2 24 | 35.4% | -22.7% | ||
| Q1 24 | 60.0% | -10.4% |
资本支出强度IRWDRDI
| Q4 25 | 0.0% | 0.3% | ||
| Q3 25 | 0.0% | 1.0% | ||
| Q2 25 | 0.0% | 0.6% | ||
| Q1 25 | 0.1% | 0.6% | ||
| Q4 24 | 0.0% | 1.7% | ||
| Q3 24 | 0.0% | 4.0% | ||
| Q2 24 | 0.1% | 0.5% | ||
| Q1 24 | 0.1% | 4.3% |
现金转化率IRWDRDI
| Q4 25 | — | — | ||
| Q3 25 | 1.19× | — | ||
| Q2 25 | -0.64× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 6.74× | — | ||
| Q3 24 | 2.71× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
IRWD
暂无分部数据
RDI
| Cinema Exhibition Segment | $46.9M | 93% |
| Real Estate Revenue | $3.4M | 7% |
